Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mercantile Bank | MBWM | Nov 14, 2024 | 49.45 | -0.22 |
Mercer International | MERC | Nov 14, 2024 | 6.35 | -1.55 |
Merchants Bancorp | MBIN | Nov 14, 2024 | 40.37 | -0.93 |
Merchants Bancorp B | MBINO | Nov 14, 2024 | 25.34 | +0.20 |
Merchants Bancorp C Pref | MBINN | Nov 14, 2024 | 22.70 | +0.09 |
Merchants Bancorp Pref D | MBINM | Nov 14, 2024 | 26.66 | +0.79 |
Merck & Co | MRK | Nov 14, 2024 | 98.36 | -0.14 |
Mercurity Fintech | MFH | Nov 14, 2024 | 3.57 | -34.50 |
Mercury General | MCY | Nov 14, 2024 | 73.40 | -1.37 |
Mercury Systems | MRCY | Nov 14, 2024 | 40.84 | -5.62 |
Mereo BioPharma ADR | MREO | Nov 14, 2024 | 3.82 | -5.68 |
Meridian | MRBK | Nov 14, 2024 | 14.15 | +1.22 |
MeridianLink | MLNK | Nov 14, 2024 | 22.70 | -2.58 |
Merit Medical Systems | MMSI | Nov 14, 2024 | 101.20 | -0.47 |
Meritage Homes | MTH | Nov 14, 2024 | 181.23 | +1.86 |
Merrill Lynch & Co. | IPB | Nov 14, 2024 | 26.10 | -1.64 |
Mersana Therapeutics | MRSN | Nov 14, 2024 | 2.52 | -4.18 |
Merus N.V | MRUS | Nov 14, 2024 | 49.66 | -2.49 |
Mesa Air Group | MESA | Nov 14, 2024 | 0.88 | -0.27 |
Mesa Laboratories | MLAB | Nov 14, 2024 | 104.60 | -2.94 |
Mesa Royalty Trust | MTR | Nov 14, 2024 | 5.87 | -0.84 |
Mesabi Royalty Trust | MSB | Nov 14, 2024 | 25.81 | -1.38 |
Mesoblast ADR | MESO | Nov 14, 2024 | 11.32 | -3.29 |
Meta Materials | MMAT | Nov 14, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 14, 2024 | 577.16 | -0.49 |
Metagenomi | MGX | Nov 14, 2024 | 1.88 | -10.90 |
Metal Sky Star Acquisition | MSSA | Nov 14, 2024 | 12.00 | +3.00 |
Metalla Royalty & Streaming | MTA | Nov 14, 2024 | 3.07 | +2.33 |
Metallus | MTUS | Nov 14, 2024 | 14.79 | -3.71 |
Metals Acquisition | MTAL | Nov 14, 2024 | 12.06 | -3.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.